Literature DB >> 23392577

miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer.

Bi-Lan Li1, Cong Lu, Wen Lu, Ting-ting Yang, Junjie Qu, Xiayu Hong, Xiao-ping Wan.   

Abstract

Endometrial cancer (EC) is the most common gynecologic malignancy, but the molecular events involved in the development and progression of EC remain unclear. Certain microRNAs (miRNAs) and DICER1 play important roles in cell motility and survival. This study investigated the role of miR-130b and DICER1 in EC. We profiled miR-130b and DICER1 expression in clinical samples explored its relationship with clinical parameters. A luciferase reporter assay assessed the miR-130b targeting potential of DICER1. We show both in vitro and in vivo that miR-130b overexpression along with DICER1 dysfunction leads to tumor aggression and miRNA synthesis abnormalities that are related to cancer hallmarks through DICER1-miRNAs axis modulation. We also identify the mechanism related to this potential tumor predisposing phenotype: miR-130b and loss of DICER1 induced abnormal expression of EMT-related genes, which constitutes a loop regulation of the miR-130b-DICER1-EMT axis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392577     DOI: 10.1007/s12032-013-0484-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  20 in total

1.  Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.

Authors:  Chun Yang; Jing Cai; Qiyue Wang; Huijuan Tang; Jin Cao; Liying Wu; Zehua Wang
Journal:  Gynecol Oncol       Date:  2011-10-15       Impact factor: 5.482

Review 2.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

Authors:  Witold Filipowicz; Suvendra N Bhattacharyya; Nahum Sonenberg
Journal:  Nat Rev Genet       Date:  2008-02       Impact factor: 53.242

3.  RNAase-III enzyme Dicer maintains signaling pathways for differentiation and survival in mouse cortical neural stem cells.

Authors:  Yoko Kawase-Koga; Roger Low; Gaizka Otaegi; Andrew Pollock; Haiteng Deng; Frank Eisenhaber; Sebastian Maurer-Stroh; Tao Sun
Journal:  J Cell Sci       Date:  2010-01-26       Impact factor: 5.285

4.  Reduced expression of Dicer associated with poor prognosis in lung cancer patients.

Authors:  Yoko Karube; Hisaaki Tanaka; Hirotaka Osada; Shuta Tomida; Yoshio Tatematsu; Kiyoshi Yanagisawa; Yasushi Yatabe; Junichi Takamizawa; Shinichiro Miyoshi; Tetsuya Mitsudomi; Takashi Takahashi
Journal:  Cancer Sci       Date:  2005-02       Impact factor: 6.716

5.  Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells.

Authors:  Yajaira Suárez; Carlos Fernández-Hernando; Jordan S Pober; William C Sessa
Journal:  Circ Res       Date:  2007-03-22       Impact factor: 17.367

6.  Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma.

Authors:  Baek-Hui Kim; Soon Won Hong; Aeree Kim; Seung Ho Choi; Sun Och Yoon
Journal:  J Surg Oncol       Date:  2012-09-20       Impact factor: 3.454

7.  The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?

Authors:  Nadeem R Abu-Rustum; Qin Zhou; Alexia Iasonos; Kaled M Alektiar; Mario M Leitao; Dennis S Chi; Yukio Sonoda; Robert Soslow; Martee Hensley; Richard R Barakat
Journal:  Int J Gynecol Cancer       Date:  2011-04       Impact factor: 3.437

8.  Dicer1 functions as a haploinsufficient tumor suppressor.

Authors:  Madhu S Kumar; Ryan E Pester; Cindy Y Chen; Keara Lane; Christine Chin; Jun Lu; David G Kirsch; Todd R Golub; Tyler Jacks
Journal:  Genes Dev       Date:  2009-11-10       Impact factor: 11.361

9.  Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer-MMP-9 correlates to the grade and the stage.

Authors:  Kristina Aglund; Marita Rauvala; Ulla Puistola; Tord Angström; Taina Turpeenniemi-Hujanen; Björn Zackrisson; Ulf Stendahl
Journal:  Gynecol Oncol       Date:  2004-09       Impact factor: 5.482

Review 10.  Resistance to chemotherapy and hormone therapy in endometrial cancer.

Authors:  Parvesh Chaudhry; Eric Asselin
Journal:  Endocr Relat Cancer       Date:  2009-02-03       Impact factor: 5.678

View more
  32 in total

1.  MicroRNA-130b promotes tumor development and is associated with poor prognosis in colorectal cancer.

Authors:  Tommaso Colangelo; Alessandra Fucci; Carolina Votino; Lina Sabatino; Massimo Pancione; Carmelo Laudanna; Monica Binaschi; Mario Bigioni; Carlo Alberto Maggi; Domenico Parente; Nicola Forte; Vittorio Colantuoni
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

2.  C-Met/miR-130b axis as novel mechanism and biomarker for castration resistance state acquisition.

Authors:  A Cannistraci; G Federici; A Addario; A L Di Pace; L Grassi; G Muto; D Collura; M Signore; L De Salvo; S Sentinelli; G Simone; M Costantini; S Nanni; A Farsetti; V Coppola; R De Maria; D Bonci
Journal:  Oncogene       Date:  2017-02-13       Impact factor: 9.867

3.  Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment.

Authors:  J B Kjersem; T Ikdahl; O C Lingjaerde; T Guren; K M Tveit; E H Kure
Journal:  Mol Oncol       Date:  2013-09-21       Impact factor: 6.603

4.  MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.

Authors:  Rui-Min Chang; Jiang-Feng Xu; Feng Fang; Hao Yang; Lian-Yue Yang
Journal:  Tumour Biol       Date:  2016-02-10

Review 5.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

6.  Overexpression Pattern of miR-301b in Osteosarcoma and Its Relevance with Osteosarcoma Cellular Behaviors via Modulating SNX10.

Authors:  Yaozong Wang; Naikun Sun; Zheyi Zhang; Yuanyuan Zhou; Hongyi Liu; Xu Zhou; Ying Zhang; Yilin Zhao
Journal:  Biochem Genet       Date:  2022-06-22       Impact factor: 1.890

Review 7.  miRNAs regulated by estrogens, tamoxifen, and endocrine disruptors and their downstream gene targets.

Authors:  Carolyn M Klinge
Journal:  Mol Cell Endocrinol       Date:  2015-02-03       Impact factor: 4.102

8.  Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcoma.

Authors:  Afshin Taheriazam; Amir Jouya Talaei; Mohammad Jamshidi; Mohammadreza Shakeri; Samaneh Khoshbakht; Emad Yahaghi; Marjan Shokrani
Journal:  Diagn Pathol       Date:  2015-10-07       Impact factor: 2.644

Review 9.  Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions.

Authors:  Fei Guo; Brittany C Parker Kerrigan; Da Yang; Limei Hu; Ilya Shmulevich; Anil K Sood; Fengxia Xue; Wei Zhang
Journal:  J Hematol Oncol       Date:  2014-03-05       Impact factor: 17.388

10.  Curcumin intake affects miRNA signature in murine melanoma with mmu-miR-205-5p most significantly altered.

Authors:  Indra N Dahmke; Christina Backes; Jeannette Rudzitis-Auth; Matthias W Laschke; Petra Leidinger; Michael D Menger; Eckart Meese; Ulrich Mahlknecht
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.